Table 2. Baseline demographics and clinical characteristics.
| Characteristics | Total, n=30 No. (%) |
Intervention, n=15 No. (%) |
Control, n=15 No. (%) |
Meetings, n=5 No. (%) |
|---|---|---|---|---|
| Gender | ||||
| Female | 16 (53) | 8 (53) | 8 (53) | 3 (60) |
| Age in years | ||||
| 18–25 | 12 (40) | 4 (27) | 8 (53) | 1 (20) |
| 26–34 | 10 (33) | 7 (46) | 3 (20) | 1 (20) |
| 35–60 | 8 (27) | 4 (27) | 4 (27) | 3 (60) |
| Combined Symptom Medication Score | ||||
| 0.3–1.0 | 11 (37) | 5 (33) | 6 (40) | – |
| 1.1–1.5 | 10 (33) | 6 (40) | 4 (27) | – |
| 1.6–4.0 | 9 (30) | 4 (27) | 5 (33) | – |